Helixgate https://validator.w3.org/feed/docs/rss2.html Pregnancy Sickness Study Identifies New Genetic Links MSF says Gilead’s lenacapavir supply ‘not nearly enough’; PolyPeptide’s strategic review FDA weighs support for compounding popular peptides Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns Can Europe turn world-class science into world-class scale? Obesity’s explosive growth continues as Q1 deals exceed total 2025 value STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more Revolution doubles stock offering target to $2B following pancreatic cancer win Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma The mental health parity gap is gaping Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search Lilly’s obesity pill heads for diabetes filing after heart risk trial STAT+: 7 key issues we’re watching as RFK Jr. faces a Congressional gauntlet Opinion: STAT+: The medical AI revolution requires rethinking health care’s architecture Freya Biosciences advances microbial treatment for IVF implantation failure Biopharmas pull back on layoffs in Q1 Biotech stocks are on a tear again STAT+: CMS proposes rolling back breakthrough device payment flexibilities STAT+: Roche to launch another Elevidys trial, with eyes on European approval Fujifilm Biotechnologies Opens New QC Lab in Denmark Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers Digital Twin Process Could Slash Microbial Protein Costs In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic Biogen filing reveals Apellis deal details; Telix raises $600M Novel Targets for Complex Cancer Revealed by Genetic Regulatory Node Mapping Tampa General’s AI journey Research collaboration to ‘strengthen pandemic preparedness’  Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic Astellas’ consolidation efforts to impact 50 Universal Cells employees STAT+: Novartis CEO joins Anthropic’s board Whitepaper: CDMOs at a Crossroads China dominates big licensing deals as M&A starts 2026 with a bang Trump DOJ report says Biden administration treated anti-abortion protestors unfairly Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data Terremoto raises $108M to make an ‘earthquake’ in small molecule space STAT+: New Bain biotech startup, building on BMS drugs, gets a name and a CEO J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen Opinion: Hosting the ‘intellectual wrestling match’ between MAHA, public health Could biotech layoffs push life sciences talent to go global? 5 biopharma M&A deals where the workforce was the prize Deep dive: Checking in with the FDA An inducible base editing platform for cancer functional genomics in vivo Using versus selling lucrative PRVs: Moderna’s cautionary tale Engineered Miniature CRISPR Boosts Gene‑Editing Efficiency in Human Cells CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients Regeneron, Telix Launch Up-to-$4.3B Cancer-Focused Radiopharma Drug, Diagnostic Collaboration FDA bolsters bespoke therapy framework with new draft safety guidelines Home